NCT05864053View on ClinicalTrials.gov

(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Pain, Neuropathic
Interventions
DRUG

Ketamine

Ketamine will be administered over a 45-minute period.

DRUG

(2R,6R)-hydroxynorketamine

(2R,6R)-Hydroxynorketamine hydrochloride will be administered over a 45-minute period.

DRUG

Saline

Saline will be administered over a 45-minute period.

Trial Locations (1)

60612

RECRUITING

Rush University Medical Center, Chicago

All Listed Sponsors
collaborator

Congressionally Directed Medical Research Programs

FED

lead

Rush University Medical Center

OTHER